Search results
Results from the WOW.Com Content Network
Linaclotide, (sold under the brand name Linzess in the US and Mexico, and as Constella elsewhere) [6] is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause.
The weekly schedule is an advantage for women who prefer an oral contraceptive, but find it difficult or impractical to adhere to a daily schedule required by other oral contraceptives. [citation needed] For the first twelve weeks of use, it is advised to take the ormeloxifene pill twice per week. [6]
Plecanatide, sold under the brand name Trulance, is a medication for the treatment of chronic idiopathic constipation (CIC) [4] and irritable bowel syndrome with constipation. [5]
The pink tax is real: Products marketed toward women tend to cost more than the same products for men. On average, personal care items that are marked "for women" cost 7% more than ones aimed at ...
Oral contraceptives, abbreviated OCPs, also known as birth control pills, are medications taken by mouth for the purpose of birth control. The introduction of the birth control pill ("the Pill") in 1960 revolutionized the options for contraception, sparking vibrant discussion in the scientific and social science literature and in the media.
Sometimes provided free of charge in hospitals and family planning clinics [55] [56] [21] France: Europe: LNG and UPA available for free without prescription to minors and adults alike in pharmacies, family-planning clinics, secondary school and university infirmaries [57] [58] Gabon: Africa: 49% [59] Gambia: Africa: Import Only [60] [11 ...
Women's satisfaction with their contraception, compliance in taking the pills on time, and discontinuation rates are not significantly different between traditional and extended cycle regimens. [11] FDA has also formally approved combined pills for acne for specific brands. [15]
Comparison of the nonsteroidal antiandrogen (NSAA) bicalutamide with other antiandrogens reveals differences between the medications in terms of efficacy, tolerability, safety, and other parameters. Relative to the other first-generation NSAAs , flutamide and nilutamide , bicalutamide shows improved potency , efficacy, tolerability, and safety ...